STOCK TITAN

[Form 4] Cencora, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Cencora (COR) CEO and Director Robert P. Mauch reported insider transactions on 10/20/2025. He exercised 3,763 stock options at $86.09 per share and sold 5,097 common shares at $326.80 per share under a Rule 10b5-1 trading plan adopted on 11/15/2024.

Following these transactions, he directly owned 37,940 common shares. The non-qualified stock option had an exercise price of $86.09 and an expiration date of 11/13/2026, with the grant previously vesting in four equal installments.

Cencora (COR) CEO e Direttore, Robert P. Mauch, ha riportato operazioni insider il 20/10/2025. Ha esercitato 3.763 stock option a $86,09 per azione e ha venduto 5.097 azioni ordinarie a $326,80 per azione nell'ambito di un piano di trading Rule 10b5-1 adottato il 15/11/2024.

A seguito di queste operazioni, possedeva direttamente 37.940 azioni ordinarie. L'opzione su azioni non qualificata aveva un prezzo di esercizio di $86,09 e una data di scadenza del 13/11/2026, con l'assegnazione che in precedenza era vestita in quattro rate uguali.

Cencora (COR) CEO y Director Robert P. Mauch reportó transacciones de insider el 20/10/2025. Ejercitó 3,763 opciones sobre acciones a $86.09 por acción y vendió 5,097 acciones ordinarias a $326.80 por acción bajo un plan de trading Rule 10b5-1 adoptado el 15/11/2024.

Tras estas transacciones, poseía directamente 37,940 acciones ordinarias. La opción sobre acciones no calificada tenía un precio de ejercicio de $86.09 y una fecha de vencimiento del 13/11/2026, con la concesión previamente vest en cuatro cuotas iguales.

Cencora (COR) CEO 겸 이사 Robert P. Mauch가 2025-10-20에 내부자 거래를 보고했습니다. 그는 3,763주식매수선택권을 주당 $86.09에 행사했고, 5,097주를 주당 $326.80에 매각했습니다. 이는 2024-11-15에 채택된 Rule 10b5-1 거래 계획에 따른 것입니다.

이 거래 후 그는 직접 보유한 보통주가 37,940주입니다. 비자격 주식매수선택권의 행사 가격은 $86.09였고 만기일은 2026-11-13이며, 수여는 이전에 네 번의 동일한 분할로 vest되었습니다.

Cencora (COR) PDG et administrateur Robert P. Mauch a déclaré des transactions d'initiés le 20/10/2025. Il a exercé 3 763 options d'actions à $86,09 par action et a vendu 5 097 actions ordinaires à $326,80 par action dans le cadre d'un plan de trading Rule 10b5-1 adopté le 15/11/2024.

Suite à ces transactions, il détenait directement 37 940 actions ordinaires. L'option d'achat d'actions non qualifiée avait un prix d'exercice de $86,09 et une date d'expiration le 13/11/2026, l'attribution ayant auparavant vest en quatre versements égaux.

Cencora (COR) CEO und Direktor Robert P. Mauch meldete Insider-Transaktionen am 20.10.2025. Er übte 3.763 Aktienoptionen zu je $86,09 pro Aktie aus undverkaufte 5.097 Stammaktien zu $326,80 pro Aktie im Rahmen eines Rule-10b5-1-Handelsplans, der am 15.11.2024 verabschiedet wurde.

Nach diesen Transaktionen besaß er direkt 37.940 Stammaktien. Die nicht qualifizierte Aktienoption hatte einen Ausübungspreis von $86,09 und ein Verfallsdatum am 13.11.2026, wobei die Gewährung zuvor in vier gleichen Raten vestete.

Cencora (COR) قام الرئيس التنفيذي والمدير روبرت ب. ماوِتش بالإبلاغ عن معاملات داخلية في 20/10/2025. قام بممارسة 3,763 خيار أسهم بسعر $86.09 للسهم وبيع 5,097 سهمًا عاديًا بسعر $326.80 للسهم وفقًا لخطة تداول Rule 10b5-1 المعتمدة في 15/11/2024.

بعد هذه المعاملات، كان يمتلك مباشرة 37,940 سهمًا عاديًا. كان خيار الأسهم غير المؤهل له سعر ممارسة قدره $86.09 وتاريخ انتهاء في 13/11/2026، مع أن المنحة كانت قد vestت سابقًا في أربع دفعات متساوية.

Cencora(COR) 的 CEO 兼董事 Robert P. Mauch 于 2025-10-20 报告了内幕交易。他在每股价格为 $86.09 的情况下行使了 3,763 份股票期权,并在每股 $326.80 的价格下,按照在 2024-11-15 批准的 Rule 10b5-1 交易计划出售了 5,097 股普通股。

交易后他直接持有 37,940 股普通股。该非合格股票期权的行使价格为 $86.09,到期日为 2026-11-13,此前授予的该期权按四个等份分批归属(vest)。

Positive
  • None.
Negative
  • None.

Insights

Routine Form 4: pre-planned sale and option exercise disclosed.

The CEO executed an option exercise for 3,763 shares at an exercise price of $86.09 and sold 5,097 shares at $326.80 on 10/20/2025. The sale was made under a Rule 10b5-1 trading plan adopted on 11/15/2024, indicating pre-set instructions.

After the transactions, direct holdings were 37,940 common shares. The disclosed option expires on 11/13/2026 and had vested in four tranches. This is an administrative ownership update; actual impact depends on insider trading plan execution mechanics.

Cencora (COR) CEO e Direttore, Robert P. Mauch, ha riportato operazioni insider il 20/10/2025. Ha esercitato 3.763 stock option a $86,09 per azione e ha venduto 5.097 azioni ordinarie a $326,80 per azione nell'ambito di un piano di trading Rule 10b5-1 adottato il 15/11/2024.

A seguito di queste operazioni, possedeva direttamente 37.940 azioni ordinarie. L'opzione su azioni non qualificata aveva un prezzo di esercizio di $86,09 e una data di scadenza del 13/11/2026, con l'assegnazione che in precedenza era vestita in quattro rate uguali.

Cencora (COR) CEO y Director Robert P. Mauch reportó transacciones de insider el 20/10/2025. Ejercitó 3,763 opciones sobre acciones a $86.09 por acción y vendió 5,097 acciones ordinarias a $326.80 por acción bajo un plan de trading Rule 10b5-1 adoptado el 15/11/2024.

Tras estas transacciones, poseía directamente 37,940 acciones ordinarias. La opción sobre acciones no calificada tenía un precio de ejercicio de $86.09 y una fecha de vencimiento del 13/11/2026, con la concesión previamente vest en cuatro cuotas iguales.

Cencora (COR) CEO 겸 이사 Robert P. Mauch가 2025-10-20에 내부자 거래를 보고했습니다. 그는 3,763주식매수선택권을 주당 $86.09에 행사했고, 5,097주를 주당 $326.80에 매각했습니다. 이는 2024-11-15에 채택된 Rule 10b5-1 거래 계획에 따른 것입니다.

이 거래 후 그는 직접 보유한 보통주가 37,940주입니다. 비자격 주식매수선택권의 행사 가격은 $86.09였고 만기일은 2026-11-13이며, 수여는 이전에 네 번의 동일한 분할로 vest되었습니다.

Cencora (COR) PDG et administrateur Robert P. Mauch a déclaré des transactions d'initiés le 20/10/2025. Il a exercé 3 763 options d'actions à $86,09 par action et a vendu 5 097 actions ordinaires à $326,80 par action dans le cadre d'un plan de trading Rule 10b5-1 adopté le 15/11/2024.

Suite à ces transactions, il détenait directement 37 940 actions ordinaires. L'option d'achat d'actions non qualifiée avait un prix d'exercice de $86,09 et une date d'expiration le 13/11/2026, l'attribution ayant auparavant vest en quatre versements égaux.

Cencora (COR) CEO und Direktor Robert P. Mauch meldete Insider-Transaktionen am 20.10.2025. Er übte 3.763 Aktienoptionen zu je $86,09 pro Aktie aus undverkaufte 5.097 Stammaktien zu $326,80 pro Aktie im Rahmen eines Rule-10b5-1-Handelsplans, der am 15.11.2024 verabschiedet wurde.

Nach diesen Transaktionen besaß er direkt 37.940 Stammaktien. Die nicht qualifizierte Aktienoption hatte einen Ausübungspreis von $86,09 und ein Verfallsdatum am 13.11.2026, wobei die Gewährung zuvor in vier gleichen Raten vestete.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mauch Robert P.

(Last) (First) (Middle)
1 WEST FIRST AVENUE

(Street)
CONSHOHOCKEN PA 19428

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Cencora, Inc. [ COR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President & CEO
3. Date of Earliest Transaction (Month/Day/Year)
10/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/20/2025 M 3,763 A $86.09 43,037 D
Common Stock 10/20/2025 S 5,097(1) D $326.8 37,940 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-qualified Stock Option (Right to Buy) $86.09 10/20/2025 M 3,763 (2) 11/13/2026 Common Stock 3,763 $0 15,051 D
Explanation of Responses:
1. The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/15/24.
2. Exercisable in four equal installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23.
Remarks:
/s/ Elizabeth S. Campbell, attorney-in-fact for Robert P. Mauch 10/21/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Cencora Inc.

NYSE:COR

COR Rankings

COR Latest News

COR Latest SEC Filings

COR Stock Data

63.47B
185.75M
4.2%
94.03%
3.17%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
CONSHOHOCKEN